 BioPorto Diagnostics launches Rat NGAL ELISA Kit
07 Jul 2008 BioPorto has launched a new ELISA test for the determination of the acute kidney injury marker NGAL in rats. NGAL determination allows kidney injury to be detected almost as soon as it occurs, and not at the later stage when the consequences of impaired kidney function can be detected by existing routine tests and the damage has been consolidated. It is expected that the availability of NGAL ELISAs for both animals and human patients will show synergic effects. The good results already obtained in patients have stimulated the demand for NGAL tests in animals. It is also expected that NGAL research in laboratory animals will promote an increased routine use of NGAL determinations in patients. The launching of this new rat NGAL test is therefore also expected to have a positive effect on the human NGAL market. Rats are among the most...
|
|
